Dupixent Side Effects: What to Expect and When to Call Your Doctor

Dupixent (dupilumab) has one of the most favorable safety profiles among biologic medications. It has no boxed warning — unlike JAK inhibitors such as Rinvoq or Cibinqo — and is not an immunosuppressant or steroid. But it does have side effects, and understanding them in advance helps you recognize what's normal and what needs medical attention.

The Most Common Dupixent Side Effects

In clinical trials for atopic dermatitis — Dupixent's most studied indication — the most commonly reported side effects (occurring in at least 1% of patients) included:

Injection site reactions — redness, pain, swelling, or itching at the injection site. Usually mild and short-lived. Rotate injection sites with each dose to reduce this.

Conjunctivitis (pink eye) — redness, itching, or discharge from the eyes. This is the most commonly reported eye disorder with Dupixent and is more common in patients using it for atopic dermatitis.

Blepharitis — inflammation of the eyelids, causing redness, irritation, or flaking.

Dry eye — a common complaint, especially in the first weeks of treatment. Lubricating eye drops can help.

Eosinophilia — a temporary increase in eosinophil (white blood cell) count. Usually asymptomatic and resolves on its own; rarely progresses to cause symptoms.

Oral herpes (cold sores) — reported in clinical trials, though not clearly higher than in the general population with underlying atopic dermatitis.

Nasopharyngitis — runny nose or sore throat symptoms, particularly noted in asthma and EoE patients.

Eye Problems: The Side Effect That Needs Attention

Eye problems are the most clinically important common side effect of Dupixent. The drug's mechanism — blocking IL-4 and IL-13 — also reduces mucus-secreting goblet cells on the eye surface, which can cause dryness and inflammation.

Eye conditions associated with Dupixent include:

Conjunctivitis: Most cases are mild and can be managed with lubricating drops. Persistent or severe cases may need topical corticosteroid eye drops.

Keratitis (corneal inflammation): Less common but more serious. Symptoms include eye redness, pain, blurry vision, and sensitivity to light. Keratitis can cause permanent vision damage if not treated promptly — see an eye doctor immediately if you experience these symptoms.

Action steps for eye side effects:

Report any new eye symptoms to your prescriber, even if mild.

Use preservative-free lubricating eye drops throughout the day to reduce dryness.

See an ophthalmologist promptly if you have vision changes, eye pain, or light sensitivity.

Some patients with severe eye problems have successfully switched to alternative biologics (such as Adbry or Ebglyss) with better tolerance.

Serious Side Effects (Rare)

Dupixent has no boxed warning, and serious side effects are uncommon. However, they can occur:

Hypersensitivity reactions: Rare but can include anaphylaxis, angioedema (swelling of face/throat), generalized urticaria, serum sickness, and acute generalized exanthematous pustulosis (AGEP). Seek emergency care immediately for symptoms like difficulty breathing, throat swelling, or severe skin reactions.

Eosinophilic conditions: In rare cases (particularly in asthma patients), marked eosinophilia may be associated with eosinophilic pneumonia or vasculitis. Call your doctor if you develop worsening breathing, rash, or neurological symptoms after starting Dupixent.

Severe joint pain: Joint pain (arthralgia) and rare cases of inflammatory arthritis have been reported. If severe joint pain affects your ability to walk or function, contact your doctor.

What Dupixent Does NOT Cause

Compared to other treatments for the conditions Dupixent addresses, it has a notable safety advantage:

No boxed warning (unlike JAK inhibitors like Rinvoq and Cibinqo)

Not an immunosuppressant — does not broadly suppress the immune system

No liver or kidney metabolism — does not require lab monitoring

No known drug-to-drug interactions per the prescribing information

No increased risk of serious infections, blood clots, or malignancy (unlike JAK inhibitors)

Important Safety Note: Live Vaccines

You should complete all recommended vaccinations before starting Dupixent. While on Dupixent, you should not receive live vaccines (e.g., varicella zoster live vaccine, yellow fever vaccine). Non-live vaccines (including COVID-19 mRNA vaccines, flu shots, and tetanus boosters) can be administered normally — clinical studies confirmed that Dupixent does not impair the immune response to standard vaccines.

When to Call Your Doctor

Call your doctor if you experience: new or worsening eye redness, pain, or vision changes; signs of severe allergic reaction (swelling, breathing difficulty, hives); worsening asthma symptoms after stopping oral steroids; significant joint pain; or any side effect that is bothersome or not improving. For information on drug interactions and what to tell your doctor, see our post on Dupixent drug interactions.